Brief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
BRIEF-Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln June 30 (Reuters) - Prostatype Genomics AB PROGEN.ST:
SAID ON MONDAY RESOLVES ON RIGHTS ISSUE OF UNITS TO RAISE ABOUT SEK 47.4 MILLION BEFORE TRANSACTION COSTS
SUBSCRIPTION PRICE SET AT SEK 0.80 PER UNIT, EQUIVALENT TO SEK 0.10 PER SHARE
RIGHTS ISSUE IS SECURED TO ABOUT 70 PERCENT VIA SUBSCRIPTION AND UNDERWRITING COMMITMENTS OF ABOUT SEK 33.15 MILLION
SAYS FULL EXERCISE OF TO6 AND TO7 WARRANTS COULD PROVIDE ADDITIONAL PROCEEDS OF ABOUT SEK 59.2 MILLION
SUBSCRIPTION PERIOD TO RUN FROM JULY 9 UP TO AND INCLUDING JULY 23, 2026
PLANS TO USE NET PROCEEDS TO FINANCE MEDICARE REIMBURSEMENT APPROVAL PROCESS AND COMMERCIALIZATION IN US AND EUROPE
Source text for Workspace: nMFN8zFpR5
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue